Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|April 10, 2020
MODifieR: an Ensemble R Package for Inference of Disease Modules from Transcriptomics NetworksHendrik A de Weerd, Tejaswi V S Badam, David Martínez-Enguita, et al.
Scientific Reports|January 2, 2020
Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytesRebecca Riise, Lina Odqvist, Johan Mattsson, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|October 9, 2007
Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductaseJohanna Nurbo, Annette K Roos, Daniel Muthas, et al.
Analytical Chemistry|October 25, 2021
Evaluation of FOXO1 Target Engagement Using a Single-Cell Microfluidic PlatformSuhuur Osman, Claus Bendtsen, Samantha Peel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results from the Phase 2 TULIP-LN TrialAndrea Fava, Michelle Petri, Patrick G Gavin, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 6, 2013
Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytesHelen Garside, Karen F Marcoe, Jessica Chesnut-Speelman, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patientsCarla Winkler, Thomas Hochdörfer, Elisabeth Israelsson, et al.
Scandinavian Journal of Gastroenterology|September 10, 2016
Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implicationsDaniel Muthas, Anna Reznichenko, Clare A Balendran, et al.
Respiratory Research|May 30, 2021
Dysregulation of COVID-19 related gene expression in the COPD lungAlastair Watson, Lisa Öberg, Bastian Angermann, et al.
ERJ Open Research|February 25, 2026
FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthmaJonathan Corren, Fred Reid, Rachel Moate, et al.
Pageof 4